More Than a Building: Why Our Expanded Research Facilities Matter for Kids EverywhereMore Than a Building: Why Our Expanded Research Facilities Matter for Kids Everywhere https://pediatricsnationwide.org/wp-content/uploads/2023/04/RB4-Exterior-View_2020-05-27-horz-1024x624.jpg 1024 624 Dennis Durbin, MD, MSCE Dennis Durbin, MD, MSCE https://pediatricsnationwide.org/wp-content/uploads/2023/04/050918ds2226_DD-crop.jpg
- April 19, 2023
- Dennis Durbin, MD, MSCE
At Nationwide Children’s Hospital, we proudly acknowledge the significant role research has in improving patient care and overall child heath. The integration of research and clinical care is at the heart of the hospital’s strategic plan — a $3.3 billion investment over the next several years in our commitment to transform health outcomes for all children.
The Abigail Wexner Research Institute at Nationwide Children’s is a dynamic, collaborative, state-of-the-art environment for world-class research. More than 200 scientists, 100 trainees and 1,400 employees work together to advance the field of pediatric medicine. We have been a top-10 National Institutes of Health-funded freestanding pediatric research institute for more than a decade and have nearly doubled our NIH funding over the past 5 years.
To do top-tier research, and attract high-quality talent, our teams need access to advanced facilities that support their work. Our facilities are on par with the best in the world, bringing technology, functionality and aesthetics together in a way that supports the work that drives our mission.
Historically, we have made bold investments in our research infrastructure that have resulted in paradigm shifting work. We were one of the first children’s hospitals to build a Good Manufacturing Practices clinical manufacturing facility to develop viral vectors and cell therapy products for preclinical and clinical research. These early efforts contributed to the major advances in gene therapy that we’ve seen in the past 5 years, most notably with the FDA approval of Zolgensma®, which was developed in these spaces. Now, we’re on the brink of even more success. You can see more of our historical commitment to facilities and infrastructure in the timeline below.
This year, our research enterprise has grown to four dedicated buildings, totaling 800,000 square feet, as well as spaces for clinical research in the main hospital. Research Building IV, opening in May 2023, marks the next step in our evolution.
It is fully connected with Research Building III, operating as a single complex. Across the (soon-to-be) green space is a sophisticated, modern conference center. Collaboration is the heart of scientific progress, and our teams work with experts around the world. Our conference facilities open the door for more collaboration and knowledge sharing, ultimately driving pediatric research forward.
Occupants of the Research Building III/IV complex include:
- Center for Injury Research and Policy
- Center for Gene Therapy
- Center for Childhood Cancer Research
- Institute for Genomic Medicine
- Center for Regenerative Medicine
- Center for Perinatal Research
- Center for Cardiovascular Research
Our buildings are full of the brightest minds in their fields, driven by the mission to advance cures and better health for children in our community and those who never walk through our doors. While our researchers are undeniably brilliant, they are also some of the most compassionate people you will meet. A beautiful building is to be celebrated, but our team is our greatest success.
This feature was published in the Spring/Summer 2023 issue. Download the full issue.
About the author
You might also like
Enhancing Intestinal Rehabilitation Workflow with Disease-Specific Documentation ToolsEnhancing Intestinal Rehabilitation Workflow with Disease-Specific Documentation Tools https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Erin Gregory Erin Gregory https://secure.gravatar.com/avatar/?s=96&d=mm&r=g
Tissue Engineered Trachea: State of the ResearchTissue Engineered Trachea: State of the Research https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Lauren Dembeck Lauren Dembeck https://pediatricsnationwide.org/wp-content/uploads/2021/03/Dembeck_headshot.gif
Oncolytic Virus Immunotherapy Safe and Tolerable in Children With Relapsed or Refractory Solid TumorsOncolytic Virus Immunotherapy Safe and Tolerable in Children With Relapsed or Refractory Solid Tumors https://pediatricsnationwide.org/wp-content/uploads/2020/06/AdobeStock_57532575-1024x683.jpg 1024 683 Lauren Dembeck Lauren Dembeck https://pediatricsnationwide.org/wp-content/uploads/2021/03/Dembeck_headshot.gif